Myelofibrosis (MF) is a hematological condition characterized by uncontrolled bone marrow proliferation often attributed to acquired driver mutation-mediated constitutive activation of the Janus kinase 2 (JAK2)-signal transducer and the activator of the transcription signaling pathway [2]. The gene discussed is JAK2; the disease is myelofibrosis.